Logo-npj

Read This Article

Article History

Submitted: 10 Mar 2020
Accepted: 20 Mar 2020
ePublished: 24 Mar 2020

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

J Nephropharmacol. 2020;9(2): e21.
doi: 10.34172/npj.2020.21

Scopus ID: 85085256177
  Abstract View: 888
  PDF Download: 678

Epidemiology and Prevention

Drug therapy in hospitalized patients with very severe symptoms following COVID-19

Rohollah Valizadeh 1,2 ORCID logo, Nahid Dadashzadeh 3, Roya Zakeri 4, Steven James Kellner 5 ORCID logo, Mohsen Mohammad Rahimi 6 * ORCID logo

1 Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
2 Nickan Research Institute, Isfahan, Iran
3 Legal Medicine Research Center, Iranian Legal Medicine Organization, Tehran, Iran
4 Pediatrics Specialist, Tabriz University of Medical Sciences, Tabriz, Iran
5 Head International Research and Development, Mesencell Biotech International Ltd, 20-22 Wenlock Road, London, N1 7GU, UK
6 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding author: Mohammad Rahimi, Email: Mohammadrahimi@tbzmed.ac.ir
Keywords: COVID-19, Kaletra, Coronavirus, Antiviral drug, Infection, 2019 Novel coronavirus

Implication for health policy/practice/research/medical education:

To treat COVID-19, the first choice should be antiviral drugs and sometimes a small dose of anti-inflammatory drugs to reduce inflammation. In this regard, chloroquine has both features including antiviral activity and anti-inflammatory effect.

Please cite this paper as: Valizadeh R, Dadashzadeh N, Zakeri R, James Kelllner S, Rahimi MM. Drug therapy in hospitalized patients with very severe symptoms following COVID-19. J Nephropharmacol. 2020;9(2):e21. DOI: 10.34172/npj.2020.21

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 888

Your browser does not support the canvas element.

PDF Download: 678

Your browser does not support the canvas element.